We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.14B
AUM Growth
+$1.57M
Cap. Flow
-$32.5M
Cap. Flow %
-2.86%
Top 10 Hldgs %
28.69%
Holding
215
New
15
Increased
37
Reduced
105
Closed
16

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.97M
2
TER icon
Teradyne
TER
+$9.45M
3
C icon
Citigroup
C
+$9.24M
4
AKAM icon
Akamai
AKAM
+$6.49M
5
CL icon
Colgate-Palmolive
CL
+$5.83M

Sector Composition

Rank Sector Weight
1 Technology 19.94%
2 Financials 17.54%
3 Healthcare 15.18%
4 Communication Services 11.87%
5 Industrials 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDV icon
201
iShares International Select Dividend ETF
IDV
$8.51B
-16,096
Closed -$497K
LPSN icon
202
LivePerson
LPSN
$32.3M
-600
Closed -$261K
MHK icon
203
Mohawk Industries
MHK
$9.22B
-4,444
Closed -$561K
NEM icon
204
Newmont
NEM
$119B
-20,748
Closed -$742K
NRG icon
205
NRG Energy
NRG
$24.8B
-7,215
Closed -$306K
PUMP icon
206
ProPetro Holding
PUMP
$1.35B
-11,355
Closed -$256K
RMCF icon
207
Rocky Mountain Chocolate Factory
RMCF
$7.84M
-10,250
Closed -$92K
SNY icon
208
Sanofi
SNY
$104B
-6,801
Closed -$301K
TER icon
209
Teradyne
TER
$59.3B
-237,280
Closed -$9.45M
WHD icon
210
Cactus
WHD
$5.44B
-15,215
Closed -$542K
RAD
211
DELISTED
Rite Aid Corporation
RAD
-1,658
Closed -$21K
RGN
212
DELISTED
REGENERX BIOPHARMACEUTICALS
RGN
-1,721
Closed -$707K

Similar funds

Philadelphia Trust Company's Q2 2019 Portfolio in Review

As of Q2 2019, Philadelphia Trust Company held 215 positions worth $1.14B, up 0.14% from $1.13B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Philadelphia Trust Company's Q2 2019 filing shows 15 new, 37 increased, 105 reduced and 16 closed positions. Its largest new stake was Corteva: 458,930 shares worth $13.6M. The largest sale was Apple, an estimated $9.97M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Philadelphia Trust Company's largest Q2 2019 buy was Corteva: 458,930 shares worth $13.6M.
  • Philadelphia Trust Company added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $8.64M increase.
  • Philadelphia Trust Company's biggest Q2 2019 reduction was Apple, cutting an estimated $9.97M.
  • Philadelphia Trust Company fully exited Teradyne in Q2 2019, selling an estimated $9.45M.
  • Philadelphia Trust Company's ten largest holdings make up 29% of its $1.14B portfolio in Q2 2019.
  • Philadelphia Trust Company opened 15 new positions and closed 16 in Q2 2019.
  • Philadelphia Trust Company's portfolio value rose 0.14% quarter-over-quarter to $1.14B.

Based on Philadelphia Trust Company's 13F filing for Q2 2019, filed 8 Aug 2019.